The homeobox A9 (HOXA9) and hypermethylated cancer-1 (HIC1) promoter methylation in serum cell-free DNA samples showed an AUC of 0.95 in discrimination between ovarian cancer and healthy controls [153,154]. This evidence concerns the gene HOXA9 and ovarian cancer.